<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01021995</url>
  </required_header>
  <id_info>
    <org_study_id>920'134</org_study_id>
    <nct_id>NCT01021995</nct_id>
  </id_info>
  <brief_title>Echinacea Safety Study</brief_title>
  <official_title>Safety and Efficacy of Long-term Treatment With EchinaforceÂ® Over 4 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>A. Vogel AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>A. Vogel AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extracts produced from Echinacea purpurea are traditionally used for the prevention and the&#xD;
      acute treatment of influenzal infections like the common cold. The aim of this clinical study&#xD;
      is to assess clinical safety and efficacy of a treatment with Echinacea in comparison to&#xD;
      placebo. 750 healthy subjects with a history of equal or more than 2 cold episodes per year&#xD;
      will be recruited during October and November 2009 and will be treated with either Echinacea&#xD;
      or placebo over a period of 4 months.&#xD;
&#xD;
      Throughout the study period adverse events (AEs) and adverse drug reactions (AEs with at&#xD;
      least a possible causal relation to the treatment) will be recorded.&#xD;
&#xD;
      Common cold related symptoms will be recorded in a daily diary.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Adverse Drug Reactions</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>efficacy</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">757</enrollment>
  <condition>Infections</condition>
  <arm_group>
    <arm_group_label>echinacea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>echinacea</intervention_name>
    <description>drops, 0.9 ml, tid for 4 months</description>
    <arm_group_label>echinacea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>drops, 0.9 ml tid for 4 months</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  On average more than 2 cold episodes per year&#xD;
&#xD;
          -  Age above 18 years&#xD;
&#xD;
          -  Good physical condition&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women without appropriate and effective contraception&#xD;
&#xD;
          -  Participation in a clinical trial 30 days prior to this trial&#xD;
&#xD;
          -  Pregnant or breast feeding women&#xD;
&#xD;
          -  Subjects with pre-existing cold symptoms for more than 24h at inclusion&#xD;
&#xD;
          -  Concurrent participation in another clinical trial&#xD;
&#xD;
          -  Intake of antimicrobial and/or antiviral medications at inclusion&#xD;
&#xD;
          -  Alcohol and/or drug abuse, narcotic drug addiction before and during trial (more than&#xD;
             50 gr and / or 10 cigarettes per day)&#xD;
&#xD;
          -  Psychiatric disorders which may influence the results of the trial,&#xD;
&#xD;
          -  epilepsy, suicide attempts&#xD;
&#xD;
          -  Planned surgical intervention during the trial.&#xD;
&#xD;
          -  Serious chronic diseases which influence the absorption, metabolism and the&#xD;
             elimination of the investigational product, especially progressive systemic illnesses&#xD;
             like tuberculosis, leukaemia,&#xD;
&#xD;
          -  collagen disorders and multiple sclerosis&#xD;
&#xD;
          -  Known AIDS, HIV-infections and autoimmune diseases&#xD;
&#xD;
          -  Known diabetes mellitus (type 1)&#xD;
&#xD;
          -  Corticosteroid-treated asthma&#xD;
&#xD;
          -  Atopic and allergic subjects (under medicinal treatment)&#xD;
&#xD;
          -  Known allergy to plants of the composite family (Asteraceae)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiff School of Biosciences</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF103AX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <study_first_submitted>November 30, 2009</study_first_submitted>
  <study_first_submitted_qc>November 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2009</study_first_posted>
  <last_update_submitted>July 22, 2014</last_update_submitted>
  <last_update_submitted_qc>July 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Safety of Echinacea in comparison to placebo</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

